SGLT2 inhibitors in fabry disease: a real-world evaluation of cardiac and renal biomarker response
12 May 2026 (08:30 - 09:30)
Organised by: 
Abstract
Slides
About the speaker
Northern General Hospital, Sheffield (United Kingdom of Great Britain & Northern Ireland)
1 More presentation in this session
Miss T. Nguyen (Prague, CZ)
Access the full session
The Event
Heart Failure 2026
12 May 2026
08:30 CET
